National and Kapodistrian University of Athens
Αξιολόγηση του άξονα CD40/CD40L ως βιοδείκτη πρόγνωσης και καρδιοτοξικότητας σε ασθενείς με καρκίνο του μαστού
Abstract
dc:descriptionSome breast cancer treatments can affect the heart, even when they are effective against cancer. Detecting early signs of heart injury during treatment is important so that doctors can monitor patients more closely and reduce the risk of long-term heart problems. This study examines whether changes in two blood markers linked to inflammation, CD40 and CD40 ligand, are associated with the development of reduced heart function in women receiving treatment for breast cancer. Wer aim to determine whether repeated measurement of these markers during therapy can help identify patients who may be at higher risk of treatment-related heart dysfunction. If confirmed in larger studies, these findings may support the development of better monitoring strategies in cardio-oncology and improve understanding of how inflammation contributes to heart injury during cancer treatment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Efthymiou, Georgia
- Ευθυμίου, Γεωργία
Subjects
dc:subject × 15- Προγνωστικοί βιοδείκτες
- Καρδιοτοξικότητα
- CD40/CD40L
- Αντικαρκινική θεραπεία
- Prognostic biomarkers
- Cardiotoxicity
- Anticancer therapy
- Ιατρική Βιοτεχνολογία
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Κλινική ιατρική, γενικά
- Medical Biotechnology
- Medical and Health Sciences
- Clinical Medicine
- Clinical medicine, general
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62914